Q2 EPS Estimate for Soleno Therapeutics Boosted by Analyst
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Equities research analysts at HC Wainwright boosted their Q2 2026 earnings per share (EPS) estimates for Soleno Therapeutics in a research note issued to investors on Friday, May 23rd. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.17 per share for the quarter, […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Equities research analysts at HC Wainwright boosted their Q2 2026 earnings per share (EPS) estimates for Soleno Therapeutics in a research note issued to investors on Friday, May 23rd. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.17 per share for the quarter, […]
